Bacterin International Holdings, a maker and developer of bone graft material and anti-infective coatings for medical applications, has agreed to acquire Robinson MedSurg, a medical device distribution company focused primarily on maxillofacial and craniofacial surgery devices, according to a company news release.
The proposed transaction will involve an initial exchange of Bacterin common stock, valued at $1 million at the closing date, in exchange for all the assets of RMS, including approximately $500,000 of inventory, existing commercial agreements and intellectual property. In addition, upon the achievement of certain revenue goals by RMS over a two-year period, additional Bacterin common stock valued at $1 million may be remitted to RMS. The letter of intent is subject to final due diligence, the execution of definitive purchase documents and the approval of both companies' boards of directors.
Read the news release about Bacterin and Robinson MedSurg.
Read other coverage about supply chain news:
- Amerinet, St. John Companies Sign Agreement for Diagnostic Imaging Supplies
- Medtronic CFO Dispels Rumors Company Is Shying Away From GPOs
- Healthcare Organizations Struggle to Invest in Stronger Medical Equipment for Heavier Patients
The proposed transaction will involve an initial exchange of Bacterin common stock, valued at $1 million at the closing date, in exchange for all the assets of RMS, including approximately $500,000 of inventory, existing commercial agreements and intellectual property. In addition, upon the achievement of certain revenue goals by RMS over a two-year period, additional Bacterin common stock valued at $1 million may be remitted to RMS. The letter of intent is subject to final due diligence, the execution of definitive purchase documents and the approval of both companies' boards of directors.
Read the news release about Bacterin and Robinson MedSurg.
Read other coverage about supply chain news:
- Amerinet, St. John Companies Sign Agreement for Diagnostic Imaging Supplies
- Medtronic CFO Dispels Rumors Company Is Shying Away From GPOs
- Healthcare Organizations Struggle to Invest in Stronger Medical Equipment for Heavier Patients
